News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Endicott David J.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/14/2016 |
4
| Endicott David J. (Director) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 15,000 options
@ $4.02, valued at
$60.3k
|
|
| 06/23/2016 |
4
| Endicott David J. (Director) has filed a Form 4 on Zeltiq Aesthetics Inc|
Txns:
| Granted 6,199 shares
@ $28.23, valued at
$175k
|
|
| 04/26/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/26/2016 |
3
| Endicott David J. (Director) has filed a Form 3 on Zeltiq Aesthetics Inc |
| 08/28/2013 |
4/A
| Endicott David J. (Director) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 18,126 options to buy
@ $6.09, valued at
$110.4k
|
|
| 06/07/2013 |
4
| Endicott David J. (Director) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 35,000 options to buy
@ $6.09, valued at
$213.2k
|
|
| 02/22/2013 |
4
| Endicott David J. (CVP and President, AGN Med) has filed a Form 4 on ALLERGAN INC|
Txns:
| Paid exercise price by delivering 2,794 shares
@ $108.08, valued at
$302k
Granted 40,000 options to buy
@ $105.87, valued at
$4.2M
|
|
| 02/20/2013 |
4
| Endicott David J. (CVP and President, AGN Med) has filed a Form 4 on ALLERGAN INC|
Txns:
| Paid exercise price by delivering 225 shares
@ $108.02, valued at
$24.3k
|
|
| 01/23/2013 |
4/A
| Endicott David J. (CVP and President, AGN Med) has filed a Form 4 on ALLERGAN INC|
Txns:
| Sold 100 shares
@ $92.27, valued at
$9.2k
Sold 1,840 shares
@ $92.3303, valued at
$169.9k
Exercised 100 options to buy
@ $64.47, valued at
$6.4k
Exercised 1,840 options to buy
@ $64.47, valued at
$118.6k
|
|
| 11/30/2012 |
4
| Endicott David J. (Director) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 35,000 options to buy
@ $4.75, valued at
$166.3k
|
|
| 11/30/2012 |
3
| Endicott David J. (Director) has filed a Form 3 on Orexigen Therapeutics, Inc. |
| 11/30/2012 |
4
| Endicott David J. (CVP and President, AGN Med) has filed a Form 4 on ALLERGAN INC|
Txns:
| Sold 52,560 shares
@ $92.4272, valued at
$4.9M
Exercised 52,560 options to buy
@ $64.47, valued at
$3.4M
|
|
| 02/24/2012 |
4
| Endicott David J. (CVP and President, AGN Med) has filed a Form 4 on ALLERGAN INC|
Txns:
| Paid exercise price by delivering 212 shares
@ $87.27, valued at
$18.5k
|
|
| 02/22/2012 |
4
| Endicott David J. (CVP and President, AGN Med) has filed a Form 4 on ALLERGAN INC|
Txns:
| Granted 378 shares
@ $0
Granted 38,000 options to buy
@ $87.91, valued at
$3.3M
Granted 15,000 options to buy
@ $87.91, valued at
$1.3M
|
|
| 10/11/2011 |
3
| Endicott David J. (CVP and President, AGN Med US) has filed a Form 3 on ALLERGAN INC |
|
|